Gliclazide Modified Release Tablets 30mg

Gliclazide Modified Release Tablets 30mg Technical Specification:

GENERIC NAME OF THE MEDICINAL PRODUCT:

• Gliclazide Modified Release Tablets BP  30mg
  
• Gliclazide Modified Release Tablets BP  60mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

•  a) Gliclazide Modified Release Tablets BP 30mg
  Each uncoated tablet contains:
  Gliclazide BP……………………30mg
  Excipients…………………………q.s.
•  b) Gliclazide Modified Release Tablets BP 60mg
  Each uncoated tablet contains:
  Gliclazide BP……………………60mg
  Excipients…………………………q.s.

THERAPEUTIC INDICATIONS:

• Gliclazide is used to treat type 2 diabetes. It’s a medicine known as a sulfonylurea. Sulfonylureas increase the amount of insulin your pancreas makes. This lowers your blood sugar.

CAUTION & WARNING:

• CAUTION:
  Read enclosed leaflet before use.
  Keep medicine out of reach of children.
  SWALLOW WHOLE DO NOT CHEW OR CRUSH
• Warning: To be sold by retail on the prescription of a Registered Medical Practitioner only.

STORAGE & DOSAGE:

• Storage: Protect form moisture at a temperature not exceeding 25˚C. Do not freeze. Keep the container tightly closed in order to protect from moisture.
• Dosage:  As directed by the Physician.

Introduction to Gliclazide Modified Release Tablets 30mg

Gliclazide Modified Release Tablets 30mg are a widely prescribed medicine for the management of Type 2 Diabetes Mellitus in adults. Classified under the sulfonylurea group of medicines, these tablets effectively lower blood sugar levels by stimulating insulin secretion from the pancreas. By maintaining healthy glucose levels, Gliclazide prevents severe complications such as kidney failure, cardiovascular diseases, vision problems, and nerve damage.

Globally, the demand for antidiabetic medicines is on a steady rise due to the increasing prevalence of Type 2 Diabetes. As per the International Diabetes Federation (IDF), more than 530 million people worldwide are living with diabetes, creating a growing need for affordable, high-quality drugs like Gliclazide Modified Release Tablets 30mg.

This growing demand positions Taj Pharma as one of the leading and most reliable Gliclazide Modified Release Tablets 30mg manufacturers, suppliers, and exporters from India.

In-depth Details for Importers, Exporters, and Global Buyers

When choosing a reliable partner for Gliclazide Modified Release Tablets 30mg export from India, buyers and importers look for compliance, documentation, quality, and supply consistency. Taj Pharma ensures every standard is met with precision.

1. Regulatory Documentation Provided

• WHO-GMP, EU-GMP certifications

• Certificate of Pharmaceutical Product (COPP)

• CTD/eCTD dossier support

• Stability studies (Zone I–IVb)

• Free Sale Certificate (FSC)

• Certificate of Analysis (COA) with each batch

• Bioequivalence study reports (if required)

2. Packaging & Labeling

• Customized packaging available (blister, alu-alu, strip, bottle packs)

• Multi-language labeling support for export markets

• Patient information leaflets as per regulatory standards

• Tamper-proof and moisture-resistant packaging

3. Shelf-life, Storage & Dosage Form

• Shelf-life: 24 to 36 months

• Storage: Store in a cool, dry place, away from direct sunlight

• Dosage form: Modified Release Tablets (30mg)

4. Export Certifications

• WHO-GMP certified manufacturing

• EU-GMP compliant units

• COPP for multiple countries

• ISO 9001:2015 & ISO 14001:2015 certifications

• DMF-ready formulations

5. Target Export Markets

Taj Pharma supplies Gliclazide Modified Release Tablets 30mg to over 40+ countries across:

• Asia (Vietnam, Philippines, Myanmar, Cambodia)

• Africa (Kenya, Nigeria, Ghana, Tanzania, South Africa)

• Middle East (UAE, Saudi Arabia, Iraq, Yemen)

• CIS Countries (Kazakhstan, Uzbekistan, Turkmenistan)

• Latin America (Peru, Chile, Mexico)

• Europe (Ukraine, Belarus, Georgia)

Why Taj Pharma is the Most Trusted Manufacturer, Supplier & Exporter

Taj Pharma stands out as the #1 Gliclazide Modified Release Tablets 30mg manufacturer in India due to its strong commitment to quality, affordability, and global accessibility.

1. State-of-the-art Manufacturing

• Production facilities in Vapi, Gujarat, compliant with WHO-GMP & EU-GMP standards.

• Automated manufacturing lines ensuring contamination-free production.

• Dedicated R&D team working on advanced formulations.

2. Affordable Pricing & Quality Assurance

• Competitive pricing to support government tenders, NGOs, and private distributors.

• Each batch undergoes strict quality testing in NABL-accredited laboratories.

• Adherence to ICH, US-FDA, and EMA guidelines for global acceptability.

3. Global Presence & Supply Chain Support

• 20+ years of expertise in pharmaceutical exports.

• Strong logistics network ensuring timely delivery worldwide.

• Partnerships with distributors, hospitals, and government healthcare schemes.

4. Top 20 Countries Exporting Gliclazide Modified Release Tablets 30mg

Nigeria, Kenya, Ghana, Iraq, UAE, Saudi Arabia, Bangladesh, Sri Lanka, Vietnam, Ukraine, Uzbekistan, Colombia, Peru, Ecuador, Philippines, Tanzania, Myanmar, Cambodia, Jordan, Zambia

Technical Product Specification

If you are a buyer, importer, distributor, or seeking PCD Pharma Franchise opportunities, Taj Pharma is your most trusted partner for Gliclazide Modified Release Tablets 30mg.

With world-class certifications, global export presence, and a commitment to affordability and quality, Taj Pharma is the 1 choice for global buyers.

📞 Contact Taj Pharma today to discuss bulk orders, export partnerships, or franchise opportunities for Gliclazide Modified Release Tablets 30mg.

Top 20 FAQs  

Q1. What is Gliclazide Modified Release Tablets 30mg used for?
It is prescribed for adults with Type 2 Diabetes Mellitus to control blood sugar levels.

Q2. How does Gliclazide work?
It stimulates insulin secretion from the pancreas, lowering blood sugar.

Q3. Can it be taken with other diabetes medicines?
Yes, it is often combined with metformin or other oral antidiabetics.

Q4. What is the difference between immediate release and modified release Gliclazide?
Modified-release formulations provide longer-lasting control with fewer daily doses.

Q5. Who should not take Gliclazide Tablets?
Patients with Type 1 diabetes, diabetic ketoacidosis, severe liver or kidney disease, or sulfonylurea allergies.

Q6. Can pregnant women take Gliclazide?
It is generally not recommended. Consult your doctor.

Q7. What is the usual dosage of Gliclazide Modified Release Tablets 30mg?
Typically, one tablet daily, but dosage depends on patient needs.

Q8. What happens if you miss a dose?
Take it as soon as you remember unless it’s close to your next dose.

Q9. Can I stop taking Gliclazide suddenly?
No. Stopping may lead to hyperglycemia and diabetes complications.

Q10. What are common side effects?
Low blood sugar (hypoglycemia), nausea, stomach upset, dizziness.

Q11. How should Gliclazide Tablets be stored?
Store in a cool, dry place below 30°C.

Q12. Does Taj Pharma provide Gliclazide Tablets for government tenders?
Yes, Taj Pharma actively participates in global healthcare tenders.

Q13. Are Taj Pharma products WHO-GMP certified?
Yes, all products including Gliclazide are manufactured under WHO-GMP compliance.

Q14. Can Taj Pharma customize packaging for exports?
Yes, multilingual and customized packaging is available.

Q15. What is the shelf-life of Gliclazide MR 30mg Tablets?
24 to 36 months depending on the market requirement.

Q16. Can Gliclazide cause weight gain?
In some cases, mild weight gain may occur.

Q17. Does Taj Pharma export to Africa?
Yes, Taj Pharma is one of the leading exporters to African nations.

Q18. What certifications does Taj Pharma hold?
WHO-GMP, EU-GMP, ISO, COPP, and more.

Q19. Does Taj Pharma provide regulatory support?
Yes, complete dossier and regulatory documentation support is provided.

Q20. Why is Taj Pharma the best Gliclazide Tablets manufacturer in India?
Due to its affordable pricing, WHO-GMP-certified facilities, global distribution, and unmatched trust among importers.